Anti-TGF beta 1 antibody [EPR21143] and 2 more items

The University of Nebraska Medical Center (UNMC) has awarded a purchase order (PO) to Abcam Inc., a research reagent supplier, for the procurement of three specialized antibody products. The contract, identified as 4800161274, was issued on November 25, 2025, with a total contract value of $1,555.00 and a performance period from award date to December 1, 2025. The specific antibodies acquired include: Anti-TGF beta 1 antibody [EPR21143] priced at $535.00, Anti-SMAD3 (pS423/425) + SMAD5 (pS463/46) antibody priced at $620.00, and Anti-CD4 antibody [EPR6855] priced at $400.00.

The procurement is structured as a tax-exempt purchase order with Net 30 payment terms and F.O.B. destination shipping, to be delivered to UNMC Shipping and Receiving. The order is executed on behalf of the Board of Regents of the University of Nebraska and is governed by the university's standard Terms of Purchase. Each antibody is ordered in a 100mL quantity, suggesting these are research-grade reagents likely intended for scientific investigation or laboratory research purposes at the University of Nebraska Medical Center located in Omaha, Nebraska.